Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
98.50
-1.50 (-1.50%)
Apr 28, 2026, 5:24 PM IDT
-37.26%
Market Cap 510.87M
Revenue (ttm) 1.81B
Net Income (ttm) 4.12M
Shares Out 510.87M
EPS (ttm) 0.01
PE Ratio 124.15
Forward PE n/a
Dividend 0.04 (3.92%)
Ex-Dividend Date Dec 1, 2025
Volume 35,746
Average Volume 306,818
Open 100.00
Previous Close 100.00
Day's Range 98.00 - 103.70
52-Week Range 91.20 - 158.30
Beta 0.20
RSI 38.45
Earnings Date May 26, 2026

About Novolog (Pharm-Up 1966)

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other ... [Read more]

Sector Healthcare
Founded 1966
Employees 916
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol NVLG
Full Company Profile

Financial Performance

In 2025, Novolog (Pharm-Up 1966)'s revenue was 1.81 billion, a decrease of -10.70% compared to the previous year's 2.02 billion. Earnings were 4.12 million, a decrease of -89.59%.

Financial Statements

News

There is no news available yet.